BCRX · Biocryst Pharmaceuticals Inc · Documents

$7.94 -0.13 (-1.61%) At close · Oct 20

Market Cap

$2.03B

255.54M

Volume · Oct 20 8.46M Avg daily vol (3M) 4.3M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
8-K	—	2021-11-29	—
8-K	—	2021-11-22	2021-11-19
10-Q	—	2021-11-04	2021-09-30
8-K	—	2021-11-03	—
8-K	—	2021-09-20	2021-09-15
8-K	—	2021-09-01	2021-08-27
8-K	—	2021-08-26	2021-08-24
8-K	—	2021-08-09	2021-08-08
10-Q	—	2021-08-09	2021-06-30
8-K	—	2021-08-05	—
8-K	—	2021-08-03	2021-07-28
8-K	—	2021-07-28	2021-07-26
8-K	—	2021-06-03	—
8-K	—	2021-05-26	2021-05-25
8-K	—	2021-05-12	—
10-Q	—	2021-05-07	2021-03-31
8-K	—	2021-05-06	—
8-K	—	2021-04-30	—
8-K	—	2021-04-14	—
DEF 14A	—	2021-04-13	2021-05-25
8-K	—	2021-03-26	—
8-K	—	2021-03-22	—
8-K	—	2021-03-18	—
8-K	—	2021-03-02	—
10-K	—	2021-03-01	2020-12-31
8-K	—	2021-02-25	—
8-K	—	2021-02-25	—
8-K	—	2021-02-03	—
8-K	—	2021-01-22	—
8-K	—	2020-12-22	—
8-K	—	2020-12-22	—
8-K	—	2020-12-21	—
8-K	—	2020-12-17	2020-12-16
8-K	—	2020-12-07	—
8-K	—	2020-12-04	2020-12-03
10-Q	—	2020-11-06	2020-09-30
8-K	—	2020-11-05	—
8-K	—	2020-09-30	—
8-K	—	2020-09-03	2020-08-31
8-K	—	2020-08-31	—
8-K	—	2020-08-31	—
10-Q	—	2020-08-07	2020-06-30
8-K	—	2020-08-06	—
8-K	—	2020-08-03	—
8-K	—	2020-06-01	—
8-K	—	2020-05-13	2020-05-12
10-Q	—	2020-05-11	2020-03-31
8-K	—	2020-05-06	—
8-K	—	2020-04-10	2020-04-09
8-K	—	2020-04-02	—

Showing 101–150 of 161 filings

Key facts CIK 882796 CUSIP 09058V103 13F (30d) 26 filings 25 filers Visit website Investor relations